Abstract
Psychiatric illnesses are on the rise throughout the globe mainly due to enhanced awareness and advanced diagnostic modalities [1]. The actual prevalence is also rising due to the changing environmental factors including increasing population, lesser number of jobs, increasing competition at every step, declining moral and ethical values, job stress, altered lifestyles, lesser time available for self-care, etc. [2]. In India, the reported incidence of psychiatric disorders is much lower than the actual incidence of these diseases [3–6]. Unlike the other central nervous system (CNS) disorders, there are no anatomical defects, but there are only functional imbalances between different areas of the brain. In neurosurgical patients, the organic diseases can manifest as psychiatric disorder [7–9]. Most commonly recognised pathway leading to psychiatric disorders is deficiencies of major neurotransmitters of the brain including dopamine, norepinephrine and serotonin [10]. The pharmacological target for treatment of psychiatric illnesses is to increase the concentration of these neurotransmitters at effect site by either inhibiting the metabolism or reducing the reuptake at nerve ending. These psychotropic medications are associated with serious side effects and drug interactions [11].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaye AD, Hoover JM, Ertner RA, Sutker PB. Behavioral and psychiatric disorders. In: Fliesher LA, editor. Anesthesia and uncommon diseases. 5th ed. Philadelphia, PA: Saunders Elsevier; 2006. p. 469–92.
Chandrashekar CR, Math SB. Psychosomatic disorders in developing countries: current issues and future challenges. Curr Opin Psychiatry. 2006;19:201–6.
Sachdeva JS, Singh S, Sidhu BS, Goyal RK, Singh J. An epidemiological study of psychiatric disorders in rural Faridkot (Punjab). Indian J Psychiatry. 1986;28:317–23.
Premrajan KC, Danabalan M, Chandrasekhar R, Srinivasa DK. Prevalence of psychiatric morbidity in an urban community of Pondicherry. Indian J Psychiatry. 1993;35:99–102.
Shaji S, Verghese A, Promodu K, George B, Shibu VP. Prevalence of priority psychiatric disorders in a rural area of Kerala. Indian J Psychiatry. 1995;37:91–6.
Sharma S, Singh MM. Prevalence of mental disorders: an epidemiological study in Goa. Indian J Psychiatry. 2001;43:118–26.
Betul O, Ipek M. Brain tumor presenting with psychiatric symptoms. J Neuropsychiatry Clin Neurosci. 2011;23(4):E43–4.
Fleminger S. Long-term psychiatric disorders after traumatic brain injury. Eur J Anaesthesiol Suppl. 2008;42:123–30.
Rödholm M, Starmark JE, Ekholm S, von Esse C. Organic psychiatric disorders after aneurysmal SAH: outcome and associations with age, bleeding severity, and arterial hypertension. Acta Neurol Scand. 2002;106(1):8–18.
Morgan GE, Mikhail MS, Murray MJ. Anesthesia for patients with neurologic and psychiatric diseases. In: Morgan: clinical anaesthesiology. 4th ed. New York: Lange International; 2008. p. 647–61.
Dawson J, Karalliedde L. Drug interactions and the clinical anaesthetist. Eur J Anaesthesiol. 1998;15:172–89.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Bajwa SJ, Jindal R, Kaur J, Singh A. Psychiatric diseases: need for an increased awareness among the anesthesiologists. J Anaesthesiol Clin Pharmacol. 2011;27:440–6.
Attri JP, Bala N, Chatrath V. Psychiatric patient and anaesthesia. Indian J Anaesth. 2012;56(1):8–13.
Montalescot G, Levy Y, Frage D, Brochard L, Fantin B, Arnoux C, et al. Lithium causing a serious sinus-node dysfunction at therapeutic doses. Clin Cardiol. 1984;7:617–20.
Rosenqvist M, Bergfeldt L, Aila H, Mathé AA. Sinus node dysfunction during long-term lithium treatment. Br Heart J. 1993;70:371–5.
Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995;29:172–91.
Chand PK, Mattoo SK, Sharan P. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis. Psychiatry Clin Neurosci. 2004;58:311–8.
Milenović M, Kalezić N, Simić D, Dimitrijević D, Marković D, Dimitrijević I. Preoperative assessment and management of patient with psychiatric comorbidity. Acta Chir Iugosl. 2011;58(2):143–9.
Slørdal L, Samstad S, Bathen J, Spigset O. A lifethreatening interaction between lithium and celecoxib. Br J Clin Pharmacol. 2003;55(4):413–4.
Handler J. Lithium and antihypertensive medication: a potentially dangerous interaction. J Clin Hypertens (Greenwich). 2009;11:738–42.
Howland RH. Potential adverse effects of discontinuing psychotropic drugs. J Psychosoc Nurs Ment Health Serv. 2010;48:9–12.
Girishchandra BG, Khanna S. Phenomenology of obsessive compulsive disorder: a factor analytic approach. Indian J Psychiatry. 2001;43:306–16.
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–20.
Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999;13:100–9.
Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med. 1998;16:615–9.
Hines RL, Marschall KE. Psychiatric disease/substance abuse/drug overdose Stoelting’s: anaesthesia and co-existing disease. 5th ed. Gurgaon: Elsevier.; A division of Reed Elsevier India Private Ltd; 2010. p. 606–29.
Ladds B, Thomas P, Mejia C, Hauser D. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics. Am J Psychiatry. 2009;166:114–5.
Huyse FJ, Touw DJ, van Schijndel RS, de Lange JJ, Slaets JP. Psychotropic drugs and the perioperative period: a proposal for a guideline in elective surgery. Psychosomatics. 2006;47(1):8–22.
Practice advisory for pre-anesthesia evaluation. A report by the American Society of Anesthesiologists. Task force on pre-anesthesia evaluation approved by the house of delegates Oct 17, 2001. Last amended Oct 15, 2003. ASA, Park Ridge, IL.
Hemmings HC, Hopkins PM. Foundations of anesthesia: basic sciences for clinical practice. 2nd ed. Philadelphia: Elsevier Health Sciences; 2006. p. 346–7.
Sprung J, Distel D, Grass J, et al. Cardiovascular collapse during anesthesia in a patient with preoperatively discontinued chronic MAO inhibitory therapy. J Clin Anesth. 1996;8:662–5.
Chui PT, Chung DCW. Medications to withhold or continue in the perioperative consultation. Curr Anaesth Crit Care. 1998;9:302–6.
McFarlane HJ. Anaesthesia and the new-generation monoamine oxidase inhibitors. Anaesthesia. 1994;49:597–9.
Jefferson JW. A clinician’s guide to monitoring kidney function in lithium-treated patients. J Clin Psychiatry. 2010;71:1153–7.
Suppes T, Baldessarini RJ, Faedda GL, et al. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991;48:1082–8.
Meena KP, Vohra AK, Rajput R. Prevalence and pattern of alcohol and substance abuse in urban areas of Rohtak city. Indian J Psychiatry. 2002;44:348–52.
Ghulam R, Rahman I, Naqi S, Gupta SR. An epidemiological study of drug abuse in urban population of Madhya Pradesh. Indian J Psychiatry. 1996;38:160–5.
Jena R, Shukla TR, Hemraj P. Drug abuse in a rural community in Bihar: some psychosocial correlates. Indian J Psychiatry. 1996;38:43–6.
Rudra A, Anjan B, Chatterjee S, Sengupta S, Das T. Anaesthetic implications of substance abuse in adolescent. Indian J Anaesth. 2008;52(2):132–9.
Rudra A, Sudipta D. Postoperative pulmonary complications. Indian J Anaesth. 2006;50:89–95.
Epie N. The chewing of betal quid and oral submucosal fibrosis andanesthesia. Anesth Analg. 2005;100:1210–3.
Diaz JH, Hill GE. Hypotension with anesthesia in disulfiramtreated patient. Anesthesiology. 1979;51:355–8.
Giuffrida JG, Bizzari DV, Saure AC, et al. Anesthetic management of drug abusers. Anesth Analg. 1970;49:273–82.
Gold MS, Pottash AL, Extein I, Kleber HD. Clonidine in acute opiate withdrawal. N Engl J Med. 1980;302:1421–2.
Jage J, Heid F. Substance use disorders and anaesthesia. In: Cashman JN, Grounds RM, editors. Recent advances in anaesthesia and intensive care, vol. 23. Cambridge: Cambridge University Press; 2005. p. 195–216.
Wood PR, Soni N. Anaesthesia and substance abuse. Anaesthesia. 1989;44:672–80.
Carlisle EJ, Donnelly SM, Vasuvattakul S, et al. Glue-sniffing and distal renal tubular acidosis: sticking to the facts. J Am Soc Nephrol. 1991;1:1019–27.
Murata K, Araki S, Yokoyama K, Yamashita K, Okajima F, Nakaaki K. Changes in autonomic function as determined by ECG R-R interval variability in sandal, shoe and leather workers exposed to n-hexane, xylene and toluene. Neurotoxicology. 1994;15:867–75.
Cunnigham SR, Dalzell GW, McGirr P, Kahn MM. Myocardial infarction and primary ventricular fubrillation after glue sniffing. Br Med J. 1987;294:739–40.
Reyes de la Rocha S, Brown MA, Fortenberry JD. Pulmonary function abnormalities in intentional spray paint inhalation. Chest. 1987;92:100–4.
Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician. 2003;68:869–74.
Stoelting RK, Dierdorf SF. Psychiatric diseases and substance abuse. In: Stoelting RK, Dierdorf SF, editors. Anesthesia and co-existing disease. 4th ed. New York: Churchill Livingstone; 2002. p. 639–54.
Beattie C, Mark L, Umbricht-Schneiter A. Evaluation of the patient with alcoholism and other drug dependencies. In: Rogers MC, Tinker JH, Covino BG, Longnecker DE, editors. Principles and practice of anesthesiology. 1st ed. St. Louis: Mosby; 1993. p. 537–59.
Morris G, Magee P. Anaesthesia and past use of LSD. Can J Anaesth. 1995;42:177.
Gold MS, Washton AM, Dackis CA. Cocaine abuse neurochemistry, pharmacology, and treatment. NIDA Res Monogr. 1985;61:130–50.
Pitts DK, Marwah J. Autonomic actions of cocaine. Can J Physiol Pharmacol. 1989;67:1168–76.
Fleming JA, Byck R, Barash PG. Pharmacology and therapeutic applications of cocaine. Anesthesiology. 1990;75:518–31.
Krane EJ, Davis PJ. Drug-abusing child and adolescent. In: Motoyama EK, Davis PJ, editors. Smith’s anesthesia for infants and children. 7th ed. Philadelphia: Mosby Elsevier; 2006. p. 262–5.
Maykut MO. Health consequences of acute and chronic marijuana use. Prog Neuro-Psychopharmacol Biol Psychiatry. 1985;9:209–38.
Stoelting RK, Martz RC, Gartner J, Brown DJ, Forney RB. Effects of delta 9-tetrahydrocannabinol on halothane MAC in dogs. Anesthesiology. 1973;38:521–4.
Michel R, Adams AP. Acute amphetamine abuse. Problems during general anesthesia for neurosurgery. Anaesthesia. 1979;34:1016–9.
Johnston RR, Way WL, Miller RD. Alteration of anesthetic requirement by amphetamine. Anesthesiology. 1972;36:357–63.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jangra, K., Samagh, N. (2019). Neuroanaesthesia and Coexisting Psychiatric Problems. In: Prabhakar, H., Singhal, V., Gupta, N. (eds) Co-existing Diseases and Neuroanesthesia. Springer, Singapore. https://doi.org/10.1007/978-981-13-2086-6_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-2086-6_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2085-9
Online ISBN: 978-981-13-2086-6
eBook Packages: MedicineMedicine (R0)